Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics

Table 3

Significantly enriched pathway terms for DEGs in DLBCL. Functional and signaling pathway enrichment analyses of the DEGs were conducted using the DAVID website.

Term	KEGG Pathway	Count	P Value	Genes
hsa05202	Transcriptional misregulation in cancer	7	0.00014	NFKBIZ, FUT8, LMO2, CCND2, BCL2A1, ETV6, CDK14
hsa04672	Intestinal immune network for IgA production	4	0.001522437	CCR10, TNFRSF13B,; AICDA, HLA-DOB
hsa05340	Primary immunodeficiency	3	0.011947217	TNFRSF13B, AICDA, BLNK
hsa04640	Hematopoietic cell lineage	3	0.06510351	IL2RA, CD44, MME
hsa04064	NF-kappa B signaling pathway	3	0.067811577	CFLAR, BCL2A1, BLNK
hsa00533	Glycosaminoglycan biosynthesis - keratan sulfate	2	0.071387272	FUT8, CHST2